orthophosphoric acid(318g/L) benzalkonium Cl(100g/L) others - search results

zantac syrup

glaxo smith kline (israel) ltd - ranitidine as hydrochloride - syrup - ranitidine as hydrochloride 150 mg / 10 ml - ranitidine - ranitidine - adults:zantac syrup is indicated for the treatment of duodenal ulcer and benign gastric ulcer, including that associated with non-steroidal anti-inflammatory agents. zantac syrup is also indicated for the treatment of post-operative ulcer, zollinger-ellison syndrome and oesophageal reflux disease including long term management of healed oesophagitis. zantac syrup is indicated for the following conditions where reduction of gastric secretion and acid output is desirable; the prophylaxis of gastro-intestinal haemorrhage from stress ulceration in seriously ill patients and before general anaesthesia in patients considered to be at risk of acid aspiration (mendelson's syndrome), particularly obstetric patients during labour. children (3 to 18 years):short term treatment of peptic ulcer. treatment of gastro-oesophageal reflux, including reflux oesophagitis and symptomatic relief of gastro-oesophageal reflux disease.

Malta - English - Medicines Authority

zantac syrup

glaxo wellcome uk limited 980 great west road, brentford, middlesex, tw8 9gs, united kingdom - ranitidine - syrup - ranitidine 150 mg - drugs for acid related disorders